Evidence map›Paper›PMID 39226913›Full record

ArticleBiofabrication2024

Endothelial extracellular vesicles enhance vascular self-assembly in engineered human cardiac tissues.

Karl T Wagner, Rick X Z Lu, Shira Landau, Sarah A Shawky, Yimu Zhao, David F Bodenstein, Luis Felipe Jiménez Vargas, Richard Jiang, Sargol Okhovatian, Ying Wang and 6 more

Abstract read
In one paragraph

Article in Biofabrication, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Karl T WagnerInstitute of Biomedical Engineering, University of Toronto, 27 King's College Circle, Toronto, ON M5S 1A1, Canada.ORCID 0000-0002-5501-7622
Rick X Z LuInstitute of Biomedical Engineering, University of Toronto, 27 King's College Circle, Toronto, ON M5S 1A1, Canada.ORCID 0000-0002-8365-7328
Shira LandauInstitute of Biomedical Engineering, University of Toronto, 27 King's College Circle, Toronto, ON M5S 1A1, Canada.ORCID 0000-0002-3514-3656
Sarah A ShawkyDepartment of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College St., Toronto, ON M5S 3M2, Canada.
Yimu ZhaoInstitute of Biomedical Engineering, University of Toronto, 27 King's College Circle, Toronto, ON M5S 1A1, Canada.ORCID 0000-0001-8265-8647
David F BodensteinInstitute of Biomedical Engineering, University of Toronto, 27 King's College Circle, Toronto, ON M5S 1A1, Canada.ORCID 0000-0003-4618-6544
Luis Felipe Jiménez VargasInstitute of Biomedical Engineering, University of Toronto, 27 King's College Circle, Toronto, ON M5S 1A1, Canada.ORCID 0009-0002-7289-0738
Richard JiangInstitute of Biomedical Engineering, University of Toronto, 27 King's College Circle, Toronto, ON M5S 1A1, Canada.
Sargol OkhovatianInstitute of Biomedical Engineering, University of Toronto, 27 King's College Circle, Toronto, ON M5S 1A1, Canada.ORCID 0000-0002-2565-7397
Ying WangInstitute of Biomedical Engineering, University of Toronto, 27 King's College Circle, Toronto, ON M5S 1A1, Canada.ORCID 0000-0001-6749-3848
Chuan LiuInstitute of Biomedical Engineering, University of Toronto, 27 King's College Circle, Toronto, ON M5S 1A1, Canada.ORCID 0000-0001-7309-1095
Daniel VosoughiLatner Thoracic Laboratories, Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario M5G 2C4, Canada.
Dakota GustafsonToronto General Hospital Research Institute, University Health Network, 200 Elizabeth Street, Toronto, ON M5G 2C4, Canada.ORCID 0000-0001-8374-6331
Jason E FishToronto General Hospital Research Institute, University Health Network, 200 Elizabeth Street, Toronto, ON M5G 2C4, Canada.ORCID 0000-0003-0640-7277
Carolyn L CumminsDepartment of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College St., Toronto, ON M5S 3M2, Canada.
Milica RadisicInstitute of Biomedical Engineering, University of Toronto, 27 King's College Circle, Toronto, ON M5S 1A1, Canada.ORCID 0000-0003-1249-4135

Funding

Engineering Vascularized Cardiac MuscleR01HL076485 · NHLBI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Gordana Vunjak-Novakovic · 2005 to 2026
$9.2M
NHLBI NIH HHS R01 HL076485
6 · The paper itself

Abstract

The fabrication of complex and stable vasculature in engineered cardiac tissues represents a significant hurdle towards building physiologically relevant models of the heart. Here, we implemented a 3D model of cardiac vasculogenesis, incorporating endothelial cells (EC), stromal cells, and human induced pluripotent stem cell (iPSC)-derived cardiomyocytes (CM) in a fibrin hydrogel. The presence of CMs disrupted vessel formation in 3D tissues, resulting in the upregulation of endothelial activation markers and altered extracellular vesicle (EV) signaling in engineered tissues as determined by the proteomic analysis of culture supernatant. miRNA sequencing of CM- and EC-secreted EVs highlighted key EV-miRNAs that were postulated to play differing roles in cardiac vasculogenesis, including the let-7 family and miR-126-3p in EC-EVs. In the absence of CMs, the supplementation of CM-EVs to EC monolayers attenuated EC migration and proliferation and resulted in shorter and more discontinuous self-assembling vessels when applied to 3D vascular tissues. In contrast, supplementation of EC-EVs to the tissue culture media of 3D vascularized cardiac tissues mitigated some of the deleterious effects of CMs on vascular self-assembly, enhancing the average length and continuity of vessel tubes that formed in the presence of CMs. Direct transfection validated the effects of the key EC-EV miRNAs let-7b-5p and miR-126-3p in improving the maintenance of continuous vascular networks. EC-EV supplementation to biofabricated cardiac tissues and microfluidic devices resulted in tissue vascularization, illustrating the use of this approach in the engineering of enhanced, perfusable, microfluidic models of the myocardium.

Indexed as

Extracellular VesiclesInduced Pluripotent Stem CellsMicroRNAsMyocytes, CardiacTissue EngineeringCell ProliferationEndothelial CellsHumansHuman Umbilical Vein Endothelial CellsMyocardiumNeovascularization, PhysiologicMicroRNAscardiaccardiac tissue engineeringextracellular vesiclesheart-on-a-chipvascularization

Identifiers

PMID39226913
PMCPMC11409464

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.